Carl Zeiss to acquire Acri.Tec; B&L and Alcon settle dispute amicably; Alcon amends tender offer for Wavelight.
Carl Zeiss to acquire Acri.Tec
Carl Zeiss Meditec has announced that it intends to acquire Acri.Tec.
Acri.Tec generated sales revenues in the 2006 financial year of €15.4 million. The enterprise value calculated for the company totals €24 million and has to be reduced by the net financial debt at the closing date in order to determine the final purchase price.
B&L and Alcon settle dispute amicably
Bausch & Lomb and Alcon have settled a lawsuit that was filed recently regarding Alcon's promotional claims about Bausch & Lomb's ReNu MultiPlus solution.
Bausch & Lomb claimed that Alcon's promotional use of a chart to demonstrate the safety of contact lens solutions could negatively influence patients and/or doctors. The chart shows the safety of different solutions based on corneal staining tests, rating them with a colour coding system: green is safe, yellow means use with caution and red indicates the solution is unsafe. Bausch & Lomb alleged that the chart was produced without scientific studies or clinical evidence to back it up.
Alcon has agreed to change the red/yellow colour scheme and in light of this the lawsuit has been dismissed.
Alcon amends tender offer for Wavelight
Alcon has announced that it has amended its tender offer for Wavelight AG and waived the minimum tender offer acceptance threshold of 75% of all WaveLight outstanding shares.
The amendment extended the €15 per share offer to 25th September, 2007. Alcon now holds 70% of WaveLight shares through purchase, contractual commitment or tender.
Extending the offer period allows WaveLight shareholders to process the new information and take appropriate steps to tender their shares
Further, Carl Zeiss Meditec has announced it will not be launching a takeover bid for Wavelight. Zeiss had acquired a 5% shareholding in the firm to demonstrate its interest in a possible voluntary takeover but the company will now tender its share package to Alcon.
AAO 2024: Detail outlined for Artificial Intelligence Innovation Center at Wilmer Eye Institute
October 24th 2024During a conversation at the American Academy of Ophthalmology annual meeting in Chicago, T.Y. Alvin Liu, MD, discussed plans for the James P. Gills Jr, MD, & Heather Gills Artificial Intelligence Innovation Center at the Wilmer Eye Institute at Johns Hopkins Medicine.
AAO 2024: Transient vision loss with Alexander Fein, MD
October 21st 2024Alexander Fein, MD, spoke with the Eye Care Network to share how to approach a patient presenting with transient vision loss, what this type of vision loss can mean, and what additional testing might be needed to determine the best plan for care.